Mr. Collier joined Arbutus in June 2019 and serves as our President and Chief Executive Officer and is a member of the Board of Directors. Mr. Collier has more than 30 years of senior executive management, commercial and operational leadership experience in the pharmaceutical industry, predominantly with companies focused in anti-virals and vaccines. Prior to Arbutus, Mr. Collier served as President and General Manager, North America at ViiV Healthcare where he led the industry-leading launches of several new treatments for HIV. Prior to that, Mr. Collier held multiple senior leadership roles during his fifteen-year tenure at GlaxoSmithKline. Earlier in his career, he led the launches of new treatments for herpes and bacterial infections. Mr. Collier received his BSc in Mathematics and Management Sciences from the University of Manchester Institute of Science & Technology, UK, and served on The President’s Advisory Council on HIV/AIDS from 2014 to 2017.